Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6164 Target Snapshot

Poly [ADP-ribose] polymerase tankyrase-1 · SINGLE PROTEIN · Homo sapiens

1,206Compounds
165Assays
5Approved Drugs
1,455.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O95271. Use UniProt O95271 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O95271 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Poly [ADP-ribose] polymerase tankyrase-1 as ChEMBL target CHEMBL6164, mapped to UniProt O95271. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Poly [ADP-ribose] polymerase tankyrase-1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL6164
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O95271
Poly [ADP-ribose] polymerase tankyrase-1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Poly [ADP-ribose] polymerase tankyrase-1 is the right protein anchor across sources, using UniProt O95271 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPoly [ADP-ribose] polymerase tankyrase-1
UniProt AccessionO95271
Component TypeProtein
Sequence Length1327 aa

Poly [ADP-ribose] polymerase tankyrase-1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Poly [ADP-ribose] polymerase tankyrase-1, mapped to UniProt O95271. Sequence length is 1327 aa.

Mapped IDO95271
Review namePoly [ADP-ribose] polymerase tankyrase-1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

5
Approved
2
Phase III
3
Phase II
Assay Mix

Activity Type Distribution

IC501,436.0
KI1.0
KD18.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5989994 10.35 IC50 0.045 Preclinical
CHEMBL6052143 10.22 IC50 0.0597 Preclinical
CHEMBL5880126 10.19 IC50 0.0647 Preclinical
CHEMBL6059393 10.14 IC50 0.0724 Preclinical
CHEMBL5766123 10.05 IC50 0.0891 Preclinical
CHEMBL3110100 10.01 IC50 0.0973 Preclinical
CHEMBL5853920 10.01 IC50 0.0979 Preclinical
CHEMBL3110117 10.0 IC50 0.1 Preclinical
CHEMBL3110122 10.0 IC50 0.1 Preclinical
CHEMBL5818177 9.97 IC50 0.107 Preclinical
Distribution

pChEMBL Value Distribution

64
5.0
117
5.5
151
6.0
169
6.5
217
7.0
254
7.5
164
8.0
69
8.5
58
9.0
39
9.5
pChEMBL
Approved Drugs

Approved Drugs

TALAZOPARIB
CHEMBL3137320
Approved 2018
NIRAPARIB
CHEMBL1094636
Approved 2017
RUCAPARIB
CHEMBL1173055
Approved 2016
OLAPARIB
CHEMBL521686
Approved 2014
Assay Landscape

Assay Landscape

165
Total Assays
1,092
Tested Compounds
2
Assay Types
Binding — 162 assays, 1,092 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 101 858 7.3
cell-based format 45 108 7.0
assay format 16 126 7.1
Functional — 3 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 2 6.9
cell-based format 1 1 7.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine